Caricamento...
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
Vaccines based on recombinant proteins require adjuvant systems in order to generate Th1-type immune responses. We have developed a vaccine adjuvant system using a viscous chitosan solution and interleukin (IL)-12, a Th1-inducing cytokine. The chitosan solution is designed to create a depot of antig...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2010
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2992965/ https://ncbi.nlm.nih.gov/pubmed/20965561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2010.09.058 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|